Over 2.25 crore unutilized COVID-19 vaccine doses available with States, UTs

New Delhi: The Central government on Monday informed that more than 2.25 Crore unutilized COVID-19 vaccine doses are still available with states, union territories, and private hospitals.

The ministry further said that more than 56.81 crore (56,81,14,630) vaccine doses have been provided to States/UTs so far, through all sources.

Of this, the total consumption including wastages is 55,11,51,992 doses (as per data available at 8 AM today).

The new phase of universalization of COVID-19 vaccination commenced from June 21, 2021.

The vaccination drive has been ramped up through the availability of more vaccines, advanced visibility of vaccine availability to States and UTs for enabling better planning by them and streamlining the vaccine supply chain.

As part of the nationwide vaccination drive, the Government of India has been supporting the States and UTs by providing them COVID vaccines free of cost.

In the new phase of the universalization of the COVID-19 vaccination drive, the Union Government will procure and supply (free of cost) 75 percent of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.

  • Related Posts

    • Pharma
    • June 19, 2025
    • 72 views
    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    This small-cap pharma stock, engaged in the research, manufacturing, and marketing of generic pharmaceutical formulations across global markets, rose over 2% in today’s trade after receiving approval for its product…

    • Pharma
    • June 19, 2025
    • 106 views
    HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval

    A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval

    HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval

    ED raids three pharma units in Baddi, Nalagarh

    ED raids three pharma units in Baddi, Nalagarh

    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations